JPH08500092A - 皮膚科用組成物 - Google Patents
皮膚科用組成物Info
- Publication number
- JPH08500092A JPH08500092A JP6501088A JP50108894A JPH08500092A JP H08500092 A JPH08500092 A JP H08500092A JP 6501088 A JP6501088 A JP 6501088A JP 50108894 A JP50108894 A JP 50108894A JP H08500092 A JPH08500092 A JP H08500092A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- treatment
- coal tar
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000011280 coal tar Substances 0.000 claims abstract description 20
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 11
- 102000008186 Collagen Human genes 0.000 claims abstract description 9
- 108010035532 Collagen Proteins 0.000 claims abstract description 9
- 239000004166 Lanolin Substances 0.000 claims abstract description 9
- 229920001436 collagen Polymers 0.000 claims abstract description 9
- 229940039717 lanolin Drugs 0.000 claims abstract description 9
- 235000019388 lanolin Nutrition 0.000 claims abstract description 9
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 201000004681 Psoriasis Diseases 0.000 claims abstract description 8
- 235000004626 essential fatty acids Nutrition 0.000 claims abstract description 7
- 208000007514 Herpes zoster Diseases 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 208000017520 skin disease Diseases 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 206010000496 acne Diseases 0.000 claims abstract description 5
- 239000000739 antihistaminic agent Substances 0.000 claims abstract description 5
- 229960005188 collagen Drugs 0.000 claims abstract description 5
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 5
- 201000004384 Alopecia Diseases 0.000 claims abstract description 4
- 201000006082 Chickenpox Diseases 0.000 claims abstract description 4
- 206010046980 Varicella Diseases 0.000 claims abstract description 4
- 231100000360 alopecia Toxicity 0.000 claims abstract description 4
- 229940125715 antihistaminic agent Drugs 0.000 claims abstract description 4
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 4
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 3
- 208000002474 Tinea Diseases 0.000 claims abstract 2
- 238000011282 treatment Methods 0.000 claims description 18
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 9
- 208000024891 symptom Diseases 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000004494 ethyl ester group Chemical group 0.000 claims description 5
- 229960001730 nitrous oxide Drugs 0.000 claims description 5
- 235000013842 nitrous oxide Nutrition 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 3
- 208000009889 Herpes Simplex Diseases 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- -1 fatty acid esters Chemical class 0.000 claims description 3
- 231100000241 scar Toxicity 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 claims description 2
- 206010003645 Atopy Diseases 0.000 claims description 2
- 206010065929 Cardiovascular insufficiency Diseases 0.000 claims description 2
- 208000000112 Myalgia Diseases 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 2
- 239000005557 antagonist Substances 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 2
- 229960002733 gamolenic acid Drugs 0.000 claims description 2
- 206010021198 ichthyosis Diseases 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 2
- 208000013465 muscle pain Diseases 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 206010027654 Allergic conditions Diseases 0.000 claims 1
- 206010012434 Dermatitis allergic Diseases 0.000 claims 1
- 241000893966 Trichophyton verrucosum Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 6
- 241000086254 Arnica montana Species 0.000 abstract description 2
- 208000001034 Frostbite Diseases 0.000 abstract description 2
- 208000010201 Exanthema Diseases 0.000 abstract 1
- 208000012659 Joint disease Diseases 0.000 abstract 1
- 208000029578 Muscle disease Diseases 0.000 abstract 1
- 241000130764 Tinea Species 0.000 abstract 1
- 201000005884 exanthem Diseases 0.000 abstract 1
- 239000001272 nitrous oxide Substances 0.000 abstract 1
- 206010037844 rash Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 229940068968 polysorbate 80 Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 208000001640 Fibromyalgia Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 230000003836 peripheral circulation Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000274177 Juniperus sabina Species 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 241001444167 Picus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- HQMNCQVAMBCHCO-DJRRULDNSA-N etretinate Chemical compound CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C HQMNCQVAMBCHCO-DJRRULDNSA-N 0.000 description 1
- 229960002199 etretinate Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000014271 psoriasis 5 Diseases 0.000 description 1
- 235000001520 savin Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- IXMINYBUNCWGER-UHFFFAOYSA-M sodium;4-propoxycarbonylphenolate Chemical compound [Na+].CCCOC(=O)C1=CC=C([O-])C=C1 IXMINYBUNCWGER-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 活性成分として一酸化二窒素と、リノール酸、アラキドン酸、リノレン酸 、ガンマ−リノレン酸およびそれらの低級アルキルエステル類よりなる群から選 ばれる少なくとも一種の必須脂肪酸またはそれらのエステルとを皮膚科において 許容できる担体に担持してなる皮膚科用組成物。 2. ピクスカーブ液(コールタール溶液としても知られている。)、コラーゲ ン、ニコチンアミド、ニコチン酸、ラノリン、ビタミンE、サリチル酸メチル、 および公知のH1拮抗−抗ヒスタミン類よりなる群から選ばれる補助的活性成分 を含有する請求項1に記載の組成物。 3. 一酸化二窒素で飽和した請求項2に記載の組成物。 4. 上記組成物の必須脂肪酸成分が請求項1に列記している脂肪酸エステル類 の混合物からなる請求項1に記載の組成物。 5. 上記組成物の必須脂肪酸成分が、ビタミンFまたはビタミンFエチルエス テルとして知られている複合体から選ばれる請求項4に記載の組成物。 6. 乾癬、熱性庖疹、単純ヘルペス、帯状ヘルペス、水痘、および皮膚の湿疹 症状の治療に用いられる、補助的活性成分としてコールタール溶液を含有する請 求項2に記載の組成物。 7. ざ瘡、末梢循環不全を含む症状、しもやけ、魚鱗症、および瘢痕組織の治 療に用いられる、補助的活性成分としてコラーゲン、ニコチンアミドおよびラノ リンのうちの一種と、コールタール溶液とを含有する請求項2に記載の組成物。 8. 皮膚の過敏、湿疹、皮膚炎、白癬を伴うアトピー性およびアレルギー性症 状の治療に用いられる、補助的活性成分としてH1拮抗剤群から選ばれる抗ヒス タミン剤の一種と、コールタール溶液とを含有する請求項2に記載の組成物。 9. 筋肉痛と関節痛の治療に用いられる、補助的成分としてサリチル酸メチル 化合物を含有する請求項2に記載の組成物。 10. 化粧品用製剤として、あるいは、脱毛症の治療や褐色斑等の軽度の皮膚 症状の治療用製剤として用いられる、補助的成分としてコラーゲンおよびラノリ ンを含有する請求項2に記載の組成物。 11. 請求項1に記載の皮膚科用組成物を、該組成物の塗布を必要とする患者 に塗布することよりなる皮膚疾患の治療方法。 12. 皮膚疾患の治療に用いる皮膚科用組成物の製造における一酸化二窒素の 使用。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA924153 | 1992-06-08 | ||
| ZA924153 | 1992-06-08 | ||
| PCT/EP1993/001405 WO1993025213A1 (en) | 1992-06-08 | 1993-06-03 | Nitrous oxide containing dermatological composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08500092A true JPH08500092A (ja) | 1996-01-09 |
| JP3640392B2 JP3640392B2 (ja) | 2005-04-20 |
Family
ID=25581750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50108894A Expired - Lifetime JP3640392B2 (ja) | 1992-06-08 | 1993-06-03 | 皮膚科用組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5633284A (ja) |
| EP (1) | EP0644766B1 (ja) |
| JP (1) | JP3640392B2 (ja) |
| AT (1) | ATE177642T1 (ja) |
| AU (1) | AU667549B2 (ja) |
| CA (1) | CA2136614C (ja) |
| DE (1) | DE69324011T2 (ja) |
| DK (1) | DK0644766T3 (ja) |
| ES (1) | ES2132236T3 (ja) |
| GR (1) | GR3030525T3 (ja) |
| NO (1) | NO308192B1 (ja) |
| NZ (1) | NZ252895A (ja) |
| WO (1) | WO1993025213A1 (ja) |
| ZA (1) | ZA933895B (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09315931A (ja) * | 1996-05-28 | 1997-12-09 | Kanebo Ltd | 皮膚化粧料 |
| JP2008195702A (ja) * | 2007-02-14 | 2008-08-28 | Matsunaga Hiroko | 鶏由来コラーゲン高含有物およびその抽出方法 |
| JP2014094942A (ja) * | 2008-03-14 | 2014-05-22 | Basf Beauty Care Solutions France Sas | 免疫細胞の活性化閾値を上昇させる物質 |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| IL110380A0 (en) * | 1994-07-20 | 1994-10-21 | Agis Ind 1983 Ltd | Antiviral topical pharmaceutical compositions |
| US5833998A (en) * | 1995-11-06 | 1998-11-10 | The Procter & Gamble Company | Topical compositions for regulating the oily/shiny appearance of skin |
| BR9611523A (pt) * | 1995-11-13 | 1999-12-28 | Pitmy Int Nv | Meios de administração para drogas analgésicas, antiinflamatórias e antipiréticas contendo óxido nitroso e composições farmacêuticas contendo tais meios e drogas. |
| US6107349A (en) * | 1998-04-16 | 2000-08-22 | Mantynen; Philip R. | Method and composition for treating psoriasis |
| GB9905425D0 (en) * | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
| ATE480246T1 (de) * | 2000-07-19 | 2010-09-15 | Univ Northwest | Transport von nukleinsäuresubstanzen |
| WO2002005850A2 (en) * | 2000-07-19 | 2002-01-24 | Pitmy International N.V. | Enhancement of the action of anti-infective agents |
| US8329685B1 (en) * | 2000-07-19 | 2012-12-11 | North West University | Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
| KR100372560B1 (ko) * | 2000-11-02 | 2003-02-19 | 한국전력공사 | 숯 충진 수화겔 드레싱 및 방사선을 이용한 그의 제조방법 |
| WO2003018102A2 (en) | 2001-08-29 | 2003-03-06 | Vectura Limited | Topical administration device |
| ATE417611T1 (de) * | 2001-11-19 | 2009-01-15 | Medigene Ag | Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen |
| DE10156794B4 (de) * | 2001-11-19 | 2006-05-18 | Medigene Ag | Arzneimittel zur Behandlung von Warzen |
| US20040001878A1 (en) * | 2002-06-26 | 2004-01-01 | Deroyal Industries, Inc. | Infused wound care dressings |
| GB0217372D0 (en) * | 2002-07-25 | 2002-09-04 | Houston Edward | Psoriasis formulation and method of preparation |
| CA2524375A1 (en) * | 2003-05-22 | 2004-12-09 | Host Pharmaceuticals, Llc | Topical composition for the treatment of skin disorders and methods of using the same |
| US20050079235A1 (en) * | 2003-10-09 | 2005-04-14 | Eggert Stockfleth | Use of a polyphenol for the treatment of actinic keratosis |
| BRPI0415215B8 (pt) * | 2003-10-09 | 2021-05-25 | Medigene Ag | uso de polifenol na preparação de medicamento |
| US7115287B2 (en) | 2005-03-03 | 2006-10-03 | F.L.M., L.L.C. | Topical medicament and method of use |
| CA2644354C (en) * | 2006-02-27 | 2015-12-29 | North-West University | Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same |
| EP1998788A4 (en) * | 2006-03-01 | 2011-08-03 | Ruey J Yu | COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR |
| DE112008001135A5 (de) * | 2007-06-08 | 2010-04-15 | Bayer Consumer Care Ag | Antiinflammatorische Wirkstoffkombinationen zur Behandlung von Erkrankungen der Haut und Schleimhäute |
| GB2460445B (en) * | 2008-05-30 | 2012-07-11 | Vernolix Ltd | Treatment of ringworm |
| WO2025155909A1 (en) * | 2024-01-19 | 2025-07-24 | Hillhurst Biopharmaceuticals, Inc. | Solution of nitrous oxide for the treatment of disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3330730A (en) * | 1962-08-03 | 1967-07-11 | Colgate Palmolive Co | Pressurized emulsion quick breaking foam compositions |
| US3395215A (en) * | 1964-10-15 | 1968-07-30 | Colgate Palmolive Co | Pressurized lotion composition |
| EP0213827A3 (en) * | 1985-08-14 | 1988-04-06 | The Procter & Gamble Company | Nonfoaming cleansing mousse with skin conditioning benefits |
-
1993
- 1993-06-03 CA CA002136614A patent/CA2136614C/en not_active Expired - Lifetime
- 1993-06-03 DE DE69324011T patent/DE69324011T2/de not_active Expired - Lifetime
- 1993-06-03 ES ES93912877T patent/ES2132236T3/es not_active Expired - Lifetime
- 1993-06-03 AT AT93912877T patent/ATE177642T1/de active
- 1993-06-03 DK DK93912877T patent/DK0644766T3/da active
- 1993-06-03 JP JP50108894A patent/JP3640392B2/ja not_active Expired - Lifetime
- 1993-06-03 WO PCT/EP1993/001405 patent/WO1993025213A1/en not_active Ceased
- 1993-06-03 ZA ZA933895A patent/ZA933895B/xx unknown
- 1993-06-03 US US08/318,626 patent/US5633284A/en not_active Expired - Lifetime
- 1993-06-03 NZ NZ252895A patent/NZ252895A/en not_active IP Right Cessation
- 1993-06-03 AU AU43225/93A patent/AU667549B2/en not_active Expired
- 1993-06-03 EP EP93912877A patent/EP0644766B1/en not_active Expired - Lifetime
-
1994
- 1994-12-07 NO NO944719A patent/NO308192B1/no not_active IP Right Cessation
-
1999
- 1999-06-16 GR GR990401600T patent/GR3030525T3/el unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09315931A (ja) * | 1996-05-28 | 1997-12-09 | Kanebo Ltd | 皮膚化粧料 |
| JP2008195702A (ja) * | 2007-02-14 | 2008-08-28 | Matsunaga Hiroko | 鶏由来コラーゲン高含有物およびその抽出方法 |
| JP2014094942A (ja) * | 2008-03-14 | 2014-05-22 | Basf Beauty Care Solutions France Sas | 免疫細胞の活性化閾値を上昇させる物質 |
Also Published As
| Publication number | Publication date |
|---|---|
| NO944719L (no) | 1994-12-07 |
| CA2136614C (en) | 2002-10-22 |
| EP0644766B1 (en) | 1999-03-17 |
| CA2136614A1 (en) | 1993-12-23 |
| AU667549B2 (en) | 1996-03-28 |
| WO1993025213A1 (en) | 1993-12-23 |
| DE69324011D1 (de) | 1999-04-22 |
| DK0644766T3 (da) | 1999-10-11 |
| ES2132236T3 (es) | 1999-08-16 |
| EP0644766A1 (en) | 1995-03-29 |
| ZA933895B (en) | 1993-12-27 |
| AU4322593A (en) | 1994-01-04 |
| NZ252895A (en) | 1996-10-28 |
| NO308192B1 (no) | 2000-08-14 |
| JP3640392B2 (ja) | 2005-04-20 |
| NO944719D0 (no) | 1994-12-07 |
| GR3030525T3 (en) | 1999-10-29 |
| ATE177642T1 (de) | 1999-04-15 |
| DE69324011T2 (de) | 1999-10-07 |
| US5633284A (en) | 1997-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3640392B2 (ja) | 皮膚科用組成物 | |
| US5378461A (en) | Composition for the topical treatment of skin damage | |
| US5980875A (en) | Honey preparations | |
| US6171604B1 (en) | Honey preparations | |
| US5032400A (en) | Shark liver oil and garlic oil topical analgesic | |
| EP0738516A1 (en) | External preparation for skin protection | |
| JPH01100132A (ja) | フラバノリグナンとリン脂質との錯体を含有する薬用及び化粧用組成物 | |
| JP7421558B2 (ja) | 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物 | |
| JP2001504463A (ja) | ククイノキナッツ油を含有する医薬組成物 | |
| JP3696464B2 (ja) | コラーゲン合成促進剤及びコラーゲン代謝賦活剤 | |
| WO2013050959A1 (en) | Composition for the treatment of skin lesions | |
| US5520919A (en) | Vitamin A palmitate composition and methodology for repairing and rejuvenating human skin | |
| EP0836476B1 (en) | A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS | |
| JPS6360910A (ja) | 皮膚外用剤 | |
| JPH03227921A (ja) | ケロイド治療剤 | |
| RU2097017C1 (ru) | Средство для стимулирования роста волос и кожной регенерации | |
| RU2148397C1 (ru) | Мазь для лечения заболеваний и повреждений кожи | |
| JP4586178B2 (ja) | 火傷による損傷皮膚改善用外用剤 | |
| WO2007144723A2 (en) | Use of plants of carpobrotus edulis as anti-itching and/or anti-inflammatory agents | |
| JP6853406B1 (ja) | 抗毛嚢炎用外用組成物 | |
| US20190365735A1 (en) | Compositions and methods for treating varicose veins | |
| CA2194773A1 (en) | Method and compound for the treatment of hair loss | |
| WO2009020398A2 (en) | Skin care product | |
| KR960015725B1 (ko) | 모발처리용 조성물 | |
| JPS5988421A (ja) | 皮脂の広がりの減少組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040420 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040716 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041020 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041207 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050118 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080128 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090128 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090128 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100128 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110128 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120128 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130128 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140128 Year of fee payment: 9 |
|
| EXPY | Cancellation because of completion of term |